Gene · 6428
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis. | J Transl Med | 2024 | 38216996 | PubTator, text mining | PubMed |
| Protein interaction networks in the vasculature prioritize genes and pathways underlying coronary artery disease. | Commun Biol | 2024 | 38216744 | PubTator, text mining | PubMed |
| A super minigene with a short promoter and truncated introns recapitulates essential features of transcription and splicing regulation of the SMN1 and SMN2 genes. | Nucleic Acids Res | 2024 | 38214229 | PubTator, text mining | PubMed |
| AFB1 Triggers Lipid Metabolism Disorders through the PI3K/Akt Pathway and Mediates Apoptosis Leading to Hepatotoxicity. | Foods | 2024 | 38201191 | PubTator, text mining | PubMed |
| Targeting SRSF3 restores immune mRNA translation in microglia/macrophages following cerebral ischemia. | Mol Ther | 2024 | 38196192 | PubTator, text mining | PubMed |
| RNA m6A methylation regulators in liver cancer. | Cancer Cell Int | 2024 | 38166832 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. | Epigenetics | 2024 | 38145548 | PubTator, text mining | PubMed |
| hGRAD: A versatile "one-fits-all" system to acutely deplete RNA binding proteins from condensates. | J Cell Biol | 2024 | 38108808 | PubTator, text mining | PubMed |
| High-throughput protocol for studying pri-miRNA processing using randomized sequences. | STAR Protoc | 2024 | 38103193 | PubTator, text mining | PubMed |
| Exosomal circRNAs in gastrointestinal cancer: Role in occurrence, development, diagnosis and clinical application (Review). | Oncol Rep | 2024 | 38099408 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3. | Int Immunopharmacol | 2024 | 38043270 | PubTator, text mining | PubMed |
| Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy. | Transl Oncol | 2024 | 38016356 | PubTator, text mining | PubMed |
| Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors. | Gastroenterology | 2024 | 37995868 | PubTator, text mining | PubMed |
| An intronic RNA element modulates Factor VIII exon-16 splicing. | Nucleic Acids Res | 2024 | 37962303 | PubTator, text mining | PubMed |
| Interconnections between m6A RNA modification, RNA structure, and protein-RNA complex assembly. | Life Sci Alliance | 2024 | 37935465 | PubTator, text mining | PubMed |
| Alternative splice variants of the mitochondrial fission protein DNM1L/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancer. | bioRxiv | 2024 | 37790404 | PubTator, text mining | PubMed |
| Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes. | Geroscience | 2024 | 37751047 | PubTator, text mining | PubMed |
| Decoding m6A mRNA methylation by reader proteins in liver diseases. | Genes Dis | 2024 | 37692496 | PubTator, text mining | PubMed |
| The essential roles of m6A modification in osteogenesis and common bone diseases. | Genes Dis | 2024 | 37588215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6428/papers?page=6